Articles tagged with Naive T Cells
Researchers from The University of Osaka discovered that only a small proportion of CD8 T cells undergo sustained clonal expansion in multiple myeloma immunotherapy, leading to the strongest anti-tumor response. Early immune activity could help predict which cells will become effective cancer fighters.
Researchers at University of Alabama at Birmingham identify Gfi1 as a crucial regulator of exhausted CD8+ T cell subsets. Fine-tuning Gfi1 activity may prevent or reverse T cell exhaustion, bolstering immune checkpoint blockade therapy. The study suggests potential for improving cancer treatment and controlling chronic infections.
Researchers identify memory CD8 T cells as potential therapeutic targets for atherosclerosis in aging. The study shows that these immune cells enhance plaque buildup in the arteries of aged mice, which could lead to heart attacks and strokes.
Researchers at the University of Arizona Health Sciences received a $13.1 million grant to study how to improve immune defense in older people. The goal is to create interventions that can help combat age-related decline in T cells, leading to better health outcomes and reduced healthcare expenses.
Research reveals that m6A modifications in T cells influence cell differentiation and biological processes. The study shows that loss of m6A affects T cell signaling and survival, leading to severe inflammatory responses and colitis in mice.
Researchers found that COPD leads to premature senescence of the immune system, reducing CD4+ and CD8+ T cells. This disruption impairs the immune system, making COPD patients more susceptible to infections.
A new graft strategy has reduced chronic graft-versus-host disease in leukemia patients by depleting naïve T cells from donor blood. The approach has shown promising results, with only 7% of patients developing chronic GVHD compared to 30-60% with standard treatment.
Researchers found that memory T cells retain an 'epigenetic signature' from their effector state, allowing them to rapidly respond to future threats. This breakthrough has significant implications for vaccine development and could aid efforts to eliminate HIV from the body.
A team at TUM found that the number and type of cells produced from a single naive T cell vary widely, contradicting the prevailing hypothesis. Mathematical models may help improve vaccination strategies by understanding the probabilities involved in T cell development.
A study by University of Arizona Health Sciences reveals the existence of 'T memory cells with naive phenotype' that accumulate with aging and respond to persistent viruses. These cells may hold the key to understanding and boosting immunity in older adults, who are vulnerable to infections due to weakened immune systems.
Researchers at Johns Hopkins Medicine have developed a method using magnetic nanoparticles to train and rapidly multiply immune system white blood cells. The technique, which separates naive T cells from other cells in the blood, has shown promise in expanding these cells' numbers by an estimated 5,000 to 10,000 times.
Depletion of naïve T cells from stem cell grafts limits chronic graft-versus host disease by reducing its occurrence and severity. This approach also results in generally responsive acute GVHD to corticosteroid therapy, supporting it as a potential treatment option.
Researchers trained immune cells of mice to fight melanoma using nanoparticles and magnetic fields, with treated tumors stopping growth and six out of eight mice surviving for over four weeks. The study uses artificial antigen-presenting cells to activate naive T cells, revealing a key difference in cancer-fighting cells.
A study published in the Journal of Experimental Medicine suggests that replacing naive CD4+ T cells with memory CD4+ T cells may be a more effective approach to combating HIV. The loss of naive T cells had no effect on the maintenance of memory CD4+ T cells, whose loss proceeded similarly with or without naive cell replacements.